149 related articles for article (PubMed ID: 36042051)
21. Rising pp65 antigenemia during preemptive anticytomegalovirus therapy after allogeneic hematopoietic stem cell transplantation: risk factors, correlation with DNA load, and outcomes.
Nichols WG; Corey L; Gooley T; Drew WL; Miner R; Huang M; Davis C; Boeckh M
Blood; 2001 Feb; 97(4):867-74. PubMed ID: 11159510
[TBL] [Abstract][Full Text] [Related]
22. Novel DNA assay for cytomegalovirus detection: comparison with conventional culture and pp65 antigenemia assay.
Veal N; Payan C; Fray D; Sarol L; Blanchet O; Kouyoumdjian S; Lunel F
J Clin Microbiol; 1996 Dec; 34(12):3097-100. PubMed ID: 8940454
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of a novel real-time PCR system for cytomegalovirus DNA quantitation on whole blood and correlation with pp65-antigen test in guiding pre-emptive antiviral treatment.
Allice T; Cerutti F; Pittaluga F; Varetto S; Franchello A; Salizzoni M; Ghisetti V
J Virol Methods; 2008 Mar; 148(1-2):9-16. PubMed ID: 18045702
[TBL] [Abstract][Full Text] [Related]
24. Use of the cytomegalovirus pp65 antigenemia assay for preemptive therapy in allogeneic hematopoietic stem cell transplantation: a real-world review.
Tan BH; Chlebicka NL; Low JG; Chong TY; Chan KP; Goh YT
Transpl Infect Dis; 2008 Oct; 10(5):325-32. PubMed ID: 18627578
[TBL] [Abstract][Full Text] [Related]
25. [The prognostic value of cytomegalovirus antigenemia and viremia for the development of cytomegalovirus disease and the survival of AIDS patients].
Cartón JA; Maradona JA; de Oña M; Asensi V; Melón S; García-Alcalde ML; Rodríguez-Junquera M; Moreno-Torrico A; de Zárraga M
Med Clin (Barc); 1999 Sep; 113(6):205-9. PubMed ID: 10472608
[TBL] [Abstract][Full Text] [Related]
26. Monitoring of CMV infection: a comparison of PCR from whole blood, plasma-PCR, pp65-antigenemia and virus culture in patients after bone marrow transplantation.
Hebart H; Müller C; Löffler J; Jahn G; Einsele H
Bone Marrow Transplant; 1996 May; 17(5):861-8. PubMed ID: 8733710
[TBL] [Abstract][Full Text] [Related]
27. Clinical utility of quantitative cytomegalovirus viral load determination for predicting cytomegalovirus disease in liver transplant recipients.
Humar A; Gregson D; Caliendo AM; McGeer A; Malkan G; Krajden M; Corey P; Greig P; Walmsley S; Levy G; Mazzulli T
Transplantation; 1999 Nov; 68(9):1305-11. PubMed ID: 10573068
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the validity of preemptive therapy against cytomegalovirus disease based on antigenemia assay with a cutoff of 20 positive cells per two slides.
Sakamoto K; Nakasone H; Wada H; Yamasaki R; Ishihara Y; Kawamura K; Ashizawa M; Sato M; Terasako-Saito K; Machishima T; Kimura S; Kikuchi M; Kako S; Kanda J; Yamazaki R; Tanihara A; Nishida J; Kanda Y
PLoS One; 2013; 8(9):e73754. PubMed ID: 24040054
[TBL] [Abstract][Full Text] [Related]
29. Clinical evaluation of patients with inflammatory connective tissue diseases complicated by cytomegalovirus antigenemia.
Yoda Y; Hanaoka R; Ide H; Isozaki T; Matsunawa M; Yajima N; Shiozawa F; Miwa Y; Negishi M; Kasama T
Mod Rheumatol; 2006; 16(3):137-42. PubMed ID: 16767551
[TBL] [Abstract][Full Text] [Related]
30. Comparison of cytomegalovirus antigenemia and culture assays in patients on and off antiviral therapy.
St George K; Rinaldo CR
J Med Virol; 1999 Sep; 59(1):91-7. PubMed ID: 10440814
[TBL] [Abstract][Full Text] [Related]
31. Randomized, placebo-controlled, double-blind study of a cytomegalovirus-specific monoclonal antibody (MSL-109) for prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation.
Boeckh M; Bowden RA; Storer B; Chao NJ; Spielberger R; Tierney DK; Gallez-Hawkins G; Cunningham T; Blume KG; Levitt D; Zaia JA
Biol Blood Marrow Transplant; 2001; 7(6):343-51. PubMed ID: 11464977
[TBL] [Abstract][Full Text] [Related]
32. Comparison of commercially available antibody reagents for the cytomegalovirus pp65 antigenemia assay.
St George K; Rinaldo CR
Clin Diagn Virol; 1997 Feb; 7(3):147-52. PubMed ID: 9126683
[TBL] [Abstract][Full Text] [Related]
33. Sequential cytomegalovirus antigenemia monitoring in kidney transplant patients treated with antilymphocyte antibodies.
Ozaki KS; Pestana JO; Granato CF; Pacheco-Silva A; Camargo LF
Transpl Infect Dis; 2004 Jun; 6(2):63-8. PubMed ID: 15522106
[TBL] [Abstract][Full Text] [Related]
34. Optimization of quantitative detection of cytomegalovirus DNA in plasma by real-time PCR.
Boeckh M; Huang M; Ferrenberg J; Stevens-Ayers T; Stensland L; Nichols WG; Corey L
J Clin Microbiol; 2004 Mar; 42(3):1142-8. PubMed ID: 15004066
[TBL] [Abstract][Full Text] [Related]
35. Quantification of DNA in plasma by an automated real-time PCR assay (cytomegalovirus PCR kit) for surveillance of active cytomegalovirus infection and guidance of preemptive therapy for allogeneic hematopoietic stem cell transplant recipients.
Gimeno C; Solano C; Latorre JC; Hernández-Boluda JC; Clari MA; Remigia MJ; Furió S; Calabuig M; Tormo N; Navarro D
J Clin Microbiol; 2008 Oct; 46(10):3311-8. PubMed ID: 18753357
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and limitations of preemptive therapy against cytomegalovirus infections in heart transplant patients.
Casillo R; Grimaldi M; Ragone E; Maiello C; Marra C; De Santo L; Amarelli C; Romano G; Della Corte A; Portella G; Tripodi MF; Fortunato R; Cotrufo M; Utili R
Transplant Proc; 2004 Apr; 36(3):651-3. PubMed ID: 15110622
[TBL] [Abstract][Full Text] [Related]
37. Pp65 antigenemia and cytomegalovirus diagnosis in patients with lupus nephritis: report of a series.
Lino K; Trizzotti N; Carvalho FR; Cosendey RI; Souza CF; Klumb EM; Silva AA; Almeida JR
J Bras Nefrol; 2018; 40(1):44-52. PubMed ID: 29796586
[TBL] [Abstract][Full Text] [Related]
38. Diagnosing cytomegalovirus disease in CMV seropositive renal allograft recipients: a comparison between the detection of CMV DNAemia by polymerase chain reaction and antigenemia by CMV pp65 assay.
Lo CY; Ho KN; Yuen KY; Lui SL; Li FK; Chan TM; Lo WK; Cheng IK
Clin Transplant; 1997 Aug; 11(4):286-93. PubMed ID: 9267717
[TBL] [Abstract][Full Text] [Related]
39. CMV antigenemia and quantitative viral load assessments in hematopoietic stem cell transplant recipients.
Cardeñoso L; Pinsky BA; Lautenschlager I; Aslam S; Cobb B; Vilchez RA; Hirsch HH
J Clin Virol; 2013 Feb; 56(2):108-12. PubMed ID: 23146665
[TBL] [Abstract][Full Text] [Related]
40. Cytomegalovirus PP65 antigenemia monitoring as a guide for preemptive therapy: a cost effective strategy for prevention of cytomegalovirus disease in adult liver transplant recipients.
Kusne S; Grossi P; Irish W; St George K; Rinaldo C; Rakela J; Fung J
Transplantation; 1999 Oct; 68(8):1125-31. PubMed ID: 10551640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
